Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Other Non-Current Assets (2019 - 2025)

IDEAYA Biosciences' Other Non-Current Assets history spans 7 years, with the latest figure at $1.0 million for Q4 2025.

  • For Q4 2025, Other Non-Current Assets rose 26.09% year-over-year to $1.0 million; the TTM value through Dec 2025 reached $1.0 million, up 26.09%, while the annual FY2025 figure was $1.0 million, 26.09% up from the prior year.
  • Other Non-Current Assets for Q4 2025 was $1.0 million at IDEAYA Biosciences, up from $805000.0 in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $1.0 million in Q4 2025 and bottomed at $99000.0 in Q4 2022.
  • The 5-year median for Other Non-Current Assets is $722000.0 (2023), against an average of $512900.0.
  • The largest annual shift saw Other Non-Current Assets plummeted 65.98% in 2022 before it soared 664.65% in 2023.
  • A 5-year view of Other Non-Current Assets shows it stood at $291000.0 in 2021, then tumbled by 65.98% to $99000.0 in 2022, then skyrocketed by 664.65% to $757000.0 in 2023, then increased by 6.34% to $805000.0 in 2024, then increased by 26.09% to $1.0 million in 2025.
  • Per Business Quant, the three most recent readings for IDYA's Other Non-Current Assets are $1.0 million (Q4 2025), $805000.0 (Q3 2025), and $805000.0 (Q2 2025).